2-Chloro-N-piperidin-4-yl-isonicotinamide hydrochloride, 95.0%, 250mg

8-Bromo-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 98%, 100mg

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3-BROMOPHENYL)BUTANOIC ACID, 95%, 5g

(S)-3-Amino-3-(3-cyanophenyl)propanoic acid, 95.0%, 250mg

(4-((2-Chlorobenzyl)carbamoyl)phenyl)boronic acid, 98%, 1g

5-Amino-1-(tert-butyl)-1H-pyrrole-3-carbonitrile, 95.0%, 1g

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

1,2-Bis(4-methoxyphenyl)ethyne, 95.0%, 250mg

N-(2-aminoethyl)-2-methylpropanamide hydrochloride, 95.0%, 250mg

7-Methylthieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 95.0%, 1g

4-Methyl-6-(trifluoromethyl)pyrimidin-2-amine, 97.0%, 1g

tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate, 95%, 2g

6,7-Dibromo-2,3-dihydrobenzo[b][1,4]dioxine, 95.0%, 5g